Active Ingredient: NYSTATIN
Proprietary Name: NYSTATIN
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 100,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062670
Product Number: 001
Approval Date: Jun 18, 1987
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information